.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Illinois, Remedi has shown a consistent upward trend in the Concentrates category. Starting from a rank of 25th in January, the brand improved its position steadily, reaching 17th by April. This positive movement is accompanied by a significant increase in sales, indicating a growing consumer preference for Remedi's concentrate products. On the other hand, in the Tincture & Sublingual category, Remedi maintained a stable 3rd place ranking throughout the first four months of 2026, suggesting a strong and steady market presence in this category. The stability in ranking, despite fluctuations in sales figures, highlights a loyal customer base for their tincture products.
Conversely, in Massachusetts, Remedi's performance in the Concentrates category has been less consistent. The brand started the year in 29th place, dropped out of the top 30 in February and March, but then rebounded to 35th in April. This volatility suggests challenges in maintaining a foothold in the Massachusetts market, possibly due to increased competition or shifting consumer preferences. The fluctuation in rankings and sales could indicate the need for strategic adjustments to better cater to local market dynamics. The absence of Remedi from the top 30 in two consecutive months is a point of concern and highlights the competitive nature of the Massachusetts concentrates market.
Competitive Landscape
In the competitive landscape of concentrates in Illinois, Remedi has demonstrated a notable upward trajectory in its market position over the first four months of 2026. Starting from a rank of 25th in January, Remedi climbed to 17th by April, indicating a consistent improvement in market presence. This positive shift is particularly significant when compared to Revolution Cannabis, which experienced a decline from 8th to 16th place over the same period, suggesting a potential opportunity for Remedi to capture market share from established players. Meanwhile, Shelby County Community Services maintained a steady position around the 15th rank, and Nature's Heritage fluctuated between 18th and 21st, indicating less volatility in their market standings. Additionally, Tales & Travels emerged in March and quickly moved up to 18th by April, suggesting new competition on the horizon. These dynamics highlight Remedi's potential to further improve its rank and sales by capitalizing on the declining momentum of some competitors and the relative stability of others.
Notable Products
In April 2026, the top-performing product for Remedi was the Indica Relief RSO Syringe (0.5g) in the Concentrates category, maintaining its first-place ranking for the fourth consecutive month with sales of 1802 units. The Indica Rest RSO Dropper (0.5g) also showed strong performance, holding the second position, a recovery from its third-place rank in February. The Indica Rest RSO Syringe (0.5g) consistently ranked third, demonstrating stable demand. Within the Tincture & Sublingual category, the CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) maintained its fourth position, while the CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) continued to hold the fifth spot. Overall, the rankings for these products have shown consistency, with only minor fluctuations observed in the earlier months of 2026.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
